Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Eupraxia Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
EPRX
New York
8731
https://eupraxiapharma.com/home/default.aspx
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Eupraxia Pharmaceuticals Inc
Eupraxia Pharmaceuticals to Present Initial Results from Ongoing Phase 1b Study of EP-104GI for the Treatment of Eosinophilic Esophagitis at Upcoming Digestive Disease Week Annual Meeting 2024
- May 14th, 2024 11:00 am
Eupraxia Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
- May 8th, 2024 9:03 pm
Eupraxia Pharmaceuticals Announces Gastrointestinal Clinical Advisory Board
- May 2nd, 2024 11:00 am
Eupraxia Pharmaceuticals Announces Upcoming Presentations at the Osteoarthritis Research Society International World Congress 2024
- Apr 11th, 2024 11:00 am
Eupraxia Pharmaceuticals To Present at Bloom Burton & Co. Healthcare Investor Conference
- Apr 8th, 2024 11:00 am
Scroll